Seeing Is Believing
Currently out of the existing stock ratings of Daniel Wendorff, 2 are a BUY (50%), 2 are a HOLD (50%).
Analyst Daniel Wendorff, currently employed at ODDO, carries an average stock price target met ratio of 75% that have a potential upside of 9.46% achieved within 94 days.
Daniel Wendorff’s has documented 8 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on QGEN, Qiagen NV at 10-Oct-2022.
Analyst best performing recommendations are on QGEN (QIAGEN NV).
The best stock recommendation documented was for QGEN (QIAGEN NV) at 1/6/2020. The price target of $35 was fulfilled within 7 days with a profit of $1.49 (4.45%) receiving and performance score of 6.35.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$50
$8.73 (21.15%)
4 months 25 days ago
(27-Jun-2024)
1/3 (33.33%)
$8.9 (21.65%)
57
Buy
$54
$12.73 (30.85%)
$52
5 months 3 days ago
(18-Jun-2024)
1/7 (14.29%)
$10.25 (23.43%)
1
Hold
$45
$3.73 (9.04%)
$50
6 months 20 days ago
(01-May-2024)
3/3 (100%)
$2.19 (5.12%)
21
Buy
$51
$9.73 (23.58%)
$70
9 months 5 days ago
(16-Feb-2024)
3/6 (50%)
$7.94 (18.44%)
113
Hold
$44
$2.73 (6.61%)
$42
10 months 19 days ago
(02-Jan-2024)
2/6 (33.33%)
$0.32 (0.73%)
19
What Year was the first public recommendation made by Daniel Wendorff?